Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2001-4-23
pubmed:abstractText
To elucidate the effects of pioglitazone treatment on glucose and lipid metabolism in patients with type 2 diabetes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/C-Peptide, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Nonesterified, http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated, http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/Placebos, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonylurea Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Thiazoles, http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides, http://linkedlifedata.com/resource/pubmed/chemical/pioglitazone
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0149-5992
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
710-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:11315836-Adipose Tissue, pubmed-meshheading:11315836-Adult, pubmed-meshheading:11315836-Aged, pubmed-meshheading:11315836-Blood Glucose, pubmed-meshheading:11315836-Body Mass Index, pubmed-meshheading:11315836-C-Peptide, pubmed-meshheading:11315836-Cholesterol, pubmed-meshheading:11315836-Diabetes Mellitus, Type 2, pubmed-meshheading:11315836-Double-Blind Method, pubmed-meshheading:11315836-Fatty Acids, Nonesterified, pubmed-meshheading:11315836-Glucose Clamp Technique, pubmed-meshheading:11315836-Glucose Tolerance Test, pubmed-meshheading:11315836-Hemoglobin A, Glycosylated, pubmed-meshheading:11315836-Humans, pubmed-meshheading:11315836-Hypoglycemic Agents, pubmed-meshheading:11315836-Infusions, Intravenous, pubmed-meshheading:11315836-Insulin, pubmed-meshheading:11315836-Middle Aged, pubmed-meshheading:11315836-Placebos, pubmed-meshheading:11315836-Sulfonylurea Compounds, pubmed-meshheading:11315836-Thiazoles, pubmed-meshheading:11315836-Thiazolidinediones, pubmed-meshheading:11315836-Triglycerides
pubmed:year
2001
pubmed:articleTitle
Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.
pubmed:affiliation
University of Texas Health Science Center and Texas Diabetes Institute, San Antonio 78284-7886, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't